-- slide 0

--

  • Published on
    15-Jan-2016

  • View
    55

  • Download
    6

DESCRIPTION

1. 2. 3. 4. 5. 6. . 7. 8. 9 . 10. 11. . -- . 1. . = . 2-3 . 1-2 . 4 . 2 . 3 . 3-6 . , . : . ?. . - PowerPoint PPT Presentation

Transcript

  • --1.2.3.4.5.6.

    7.8.9.10.11.

  • = 3-6 2 4 3 1-2 :2-31.,

  • ?

  • ,,,,

  • ,, 2.? ?

  • DNA ,,73,000 DNA

  • DNA16 ! ! !

  • 1.2. 3. 4.5.6. 1.2.3.4.5.6.7. 10,000,000,000,000,000

  • DNA 21.

    2.!&

  • 3.

  • (/)

  • 1. 2. 3.Aflatoxin4.HTLV, Herpes5.6.7.8.

  • ?

    ()

  • Stopping Cancer Before It Starts 6070:

    3040. 30

  • 1990 5-A-DAY Campaign

  • 1

    2,

    3

    4,

    5.

    6,

  • / /4.

  • ()

  • ()()

    (TB)()

  • ---

    ---

  • 5.

  • Based on data from G. Chrousos and P. Gold, NIH, and B. McEwen, Rockefeller ( X )(/// ) () ()()()()////:

  • L-Theanine,, Passion flower Phosphatidylserine(),*References available upon request

  • -Beta- sitosterol,

    Garlic extract

  • 6.

  • , (:mg/dl )

  • (),,50%

  • / Adapted from Stary HC et al. Circulation 1995;92:1355-1374.

  • 50%

    13

    454

  • Braunwald E, Mark DB, Jones RH, et al. Unstable Angina: Diagnosis and Management. Clinical Practice Guideline No 10.AHCPR and NHLBI, Public Health Service, U.S. Department of Health and Human Services, 1994. /100 /0123456()0510152025

  • : MUCAMONICA 1991-1995150

  • 4%MONICA 1991-19951504%

  • / 1/10)908070605040301988 1989 1990 1991 1992 1993(1/10) 35 - 74

  • :1. 552. :=6:4

    :

    160 mg/dl

  • HDL

    ......

  • A.

    B.

    C.

    D.

  • ,() ,()()

  • 300mg () 0 (5/2) 45(5/2) 53 (5/2) 65 (5/2) 85 (5/2) 100 (5/2) 150 (5/2) 80 (5/2) 90 (5/2) 69 () 270 (5/2) 440 (5/2) 700 (5/2) 2169

  • 74% 9% 64% 10% 58% 13% () 40% 13% * 30% 19% 26% 29% * 9% 14% 20% 32% 12% 40% 4% 61% 2% 86% *(46%74%)

  • VitB6VitB12

  • 1.-- ...2.-- ...3. ...4. 5.-- .7.

  • --- : 30.6 %3,,,:10523-35

  • /

    /

    /

  • (FAO) (WHO)

    2001FAOWHO

    pH

    ,

  • 1.5 2 2.5 3 3.5 58.

  • 20%1.240%1.550%2

  • ? 20% (kg) (-80)X0.7 (-70)X0.6 >20% (15-20%) >28% (20-25%)

  • ?????

    13524

  • .,,.,.,.,,,,.,,

  • 9.

  • ?

  • 4.3.

    1.A2.

  • DB6B12K10.

  • 12000 99%

    : D:K:C: :,(receptor),

  • (Glucosamine) (GAGs),4-6

  • --,,B ,5011.,

  • (,,,,, .),,,,,,

  • SGOTSGPT BHBsAg BHBsAb B

  • (VitB,C,K)

    86,46612,215.46,5001,11171,210!,62%.,!,! ,, , , ?,,, , , ,, . ,...,, , .(, 65),, , ,, ,, 317,4-8,

    1.55 6:4 HDLLDL 2. 1.2.1850% a. b. c. d.3.HDL20~304.5. 30%10% 6. LDL-C

    ,:,,,Vit.B6Vit.B12,

    ,. .3,,,,,.,,,,!.,,,,,60-70mmHg,,!

    ,,..,.,,,,,,,,.,,,(,),,,, ,,,..,,,.,,,,,Pharmanex,2,,., , , , , , , , , , , , , , ., (kg), (-80)X0.7, (-70)X0.6, 10%, , 20%., , , , , , , , , ., , , ., , , n??n?!sizen?.

    n?n?n?

    ?

    1A2.3.4.

    ,,,,,,,,,.,,,,,,,,,,.,,,,,,.:1.,, 2.3., 4. 5.,,, ,,,(),. ,.

    ,,,,.,.(),.,,,. 9 ,30,,., 5 1 B(?):1,,300B,B,150..!

    B,20%,20%,60%,2-3,10-15.,,20,.,,,,,,,, ,.,,,,,,,,,,,,().14%,,,3/4,,,,,,,,,,,A,,,,,,,,,B,,,,,.,..,SGOT,SGPT,,GOT,GPT2,,,2,,,GOT40,GPT35,,.,.,GOT,GPT,.,,B,B,,B,.,,,.